Back to Trades
Total Value
$304.5K
Filing Date
Feb 4, 2026
1 transaction
Trade Summary
On Feb 2, 2026, Lester Rachael, Insider, reported $304.5K of CytomX Therapeutics, Inc. (CTMX) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $6.09. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- CytomX Therapeutics, Inc.
- Ticker Symbol
- CTMX
- CIK
- 0001501989
Insider Information
- Name
- Lester Rachael
- Role
- Insider
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- Feb 4, 2026
- Transaction Date
- Feb 2, 2026
- Accession Number
- 0001610717-26-000043
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | 20,000 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | CTMX derivative | 50,000 | $6.09 | Grant/Award | $304.5K |
| Feb 2, 2026 | CTMX derivative | 50,000 | — | Grant/Award | — |
Want live alerts when Lester Rachael trades again?
Download Insider Trades to track CTMX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2027, subject to the Reporting Person continuing as a service provider through each such date.
- (F2)Includes 20,000 RSUs.
- (F3)1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
- (F4)Each Performance Stock Unit ("PSU") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date.